The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value
The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
Subscribe To Our Newsletter & Stay Updated
